{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T15:02:31Z","timestamp":1770562951771,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T00:00:00Z","timestamp":1692662400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.jbo.2023.100499","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T02:54:00Z","timestamp":1693536840000},"page":"100499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A randomized trial comparing LY01011, biosimilar candidate, with the reference product denosumab (Xgeva\u00ae) in healthy Chinese subjects"],"prefix":"10.1016","volume":"42","author":[{"given":"Yanhua","family":"Ding","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changlin","family":"Dou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuren","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbo.2023.100499_b0005","doi-asserted-by":"crossref","unstructured":"Coleman RE. Clinical features of metastatic bone disease and risk of skeletal morbidity. Clin. Cancer Res. 12(20) (2006) 6243-49.","DOI":"10.1158\/1078-0432.CCR-06-0931"},{"key":"10.1016\/j.jbo.2023.100499_b0010","unstructured":"Expert Consensus on Clinical Diagnosis and treatment of malignant bone metastasis and bone-related disease. (2022) 45-46."},{"issue":"5S","key":"10.1016\/j.jbo.2023.100499_b0015","doi-asserted-by":"crossref","first-page":"813","DOI":"10.6004\/jnccn.2014.0196","article-title":"NCCN Bone Health Task Force: Key Recommendations","volume":"12","author":"Farooki","year":"2014","journal-title":"J. Natl. Comprehens. Cancer Network"},{"issue":"1","key":"10.1016\/j.jbo.2023.100499_b0020","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00774-020-01182-2","article-title":"Role of RANKL in cancer development and metastasis","volume":"39","author":"Okamoto","year":"2021","journal-title":"J. Bone Miner. Metabol."},{"key":"10.1016\/j.jbo.2023.100499_b0025","unstructured":"Amgen. XGEVA\u00ae (denosumab) U.S. Prescribing Information. [Accessed in Feb 2023]. Available from: https:\/\/dailymed.nlm.nih.gov\/dailymed\/drugInfo.cfm?setid=628f0998-1206-4001-aeee-18133aa9f3bf."},{"key":"10.1016\/j.jbo.2023.100499_b0030","unstructured":"Amgen. XGEVA\u00ae (denosumab) CHN Prescribing Information. [Accessed in Feb 2023]. Available from: http:\/\/www.mijian360.com\/drugs\/55-Denosumab.html."},{"key":"10.1016\/j.jbo.2023.100499_b0035","unstructured":"Center for Drug Evaluation, NMPA. Technical Guidelines for Clinical Pharmacokinetics of Chemical Drugs. 2005;03."},{"issue":"2","key":"10.1016\/j.jbo.2023.100499_b0040","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/PL00005830","article-title":"Serum CTX: a new marker of bone resorption that shows treatment effect more often than other markers because of low coefficient of variability and large changes with bisphosphonate therapy","volume":"66","author":"Rosen","year":"2000","journal-title":"Calcified Tissue International"},{"key":"10.1016\/j.jbo.2023.100499_b0045","volume":"107","author":"Hou","year":"2022","journal-title":"Int. Immuno. Pharmacol."},{"issue":"6","key":"10.1016\/j.jbo.2023.100499_b0050","doi-asserted-by":"crossref","first-page":"e0197984","DOI":"10.1371\/journal.pone.0197984","article-title":"pharmacokinetics, pharmacodynamics, safety, and tolerability of single dose denosumab in healthy Chinese volunteers: a randomized, single-blind, placebo-controlled study","volume":"13","author":"Chen","year":"2018","journal-title":"PLoS One1"}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137423000325?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137423000325?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T20:20:09Z","timestamp":1761942009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137423000325"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":10,"alternative-id":["S2212137423000325"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2023.100499","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A randomized trial comparing LY01011, biosimilar candidate, with the reference product denosumab (Xgeva\u00ae) in healthy Chinese subjects","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2023.100499","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100499"}}